{"transactions":[{"id":731916,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:18.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000054","document":"wk-form4_1781813773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000054/wk-form4_1781813773.xml","form_type":"4"}},{"id":975968,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T21:18:02.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":8.17,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001584516-25-000009","document":"wk-form4_1765315079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000158451625000009/wk-form4_1765315079.xml","form_type":"4"}},{"id":1403254,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:19.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107799/ownership.xml","form_type":"4"}},{"id":1403253,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:19.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107799/ownership.xml","form_type":"4"}},{"id":1403252,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:19.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107799/ownership.xml","form_type":"4"}},{"id":1403251,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T16:15:19.000Z","date":"2024-09-18","kind":"other","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-107799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107799/ownership.xml","form_type":"4"}},{"id":1403250,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T16:15:19.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-107799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107799/ownership.xml","form_type":"4"}},{"id":1478557,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-14T16:42:23.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-24-005083","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218024005083/primarydocument.xml","form_type":"4"}},{"id":1478556,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:42:23.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 10,000 shares of common stock; (ii) 10,000 RSUs from award granted on June 15, 2023; and (iii) 10,000 RSUs from award granted on June 13, 2024."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-24-005083","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218024005083/primarydocument.xml","form_type":"4"}},{"id":1671854,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T22:34:09.000Z","date":"2024-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 24, 2024, Kyowa Kirin Co., Ltd., a Japanese joint stock company (\"KKC\") acquired all outstanding ordinary shares, nominal value GBP 0.10 per share (the \"Ordinary Shares\") of Orchard Therapeutics plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006. The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement dated as of October 5, 2023 by and between KKC and the Company, these options were cancelled in exchange for (i) an amount in cash equal to the excess of the Cash Consideration ($1.60 per share) over the per share exercise price of such options, and (ii) one contractual contingent value right (each, a \"CVR\"), each representing the right to receive a contingent payment of $0.10 in cash, without interest, if a certain milestone is achieved, pursuant to the Contingent Value Rights Agreement between KKC and a rights agent mutually agreeable to the Company and KKC."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":0,"derivative":{"exercise_price":0.495,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000950170-24-007089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000095017024007089/ownership.xml","form_type":"4"}},{"id":1671853,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T22:34:09.000Z","date":"2024-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 24, 2024, Kyowa Kirin Co., Ltd., a Japanese joint stock company (\"KKC\") acquired all outstanding ordinary shares, nominal value GBP 0.10 per share (the \"Ordinary Shares\") of Orchard Therapeutics plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006. The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement dated as of October 5, 2023 by and between KKC and the Company, these options were cancelled in exchange for (i) an amount in cash equal to the excess of the Cash Consideration ($1.60 per share) over the per share exercise price of such options, and (ii) one contractual contingent value right (each, a \"CVR\"), each representing the right to receive a contingent payment of $0.10 in cash, without interest, if a certain milestone is achieved, pursuant to the Contingent Value Rights Agreement between KKC and a rights agent mutually agreeable to the Company and KKC."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":0,"derivative":{"exercise_price":0.475,"expiration_date":"2032-06-06","underlying":"Ordinary Shares","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000950170-24-007089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000095017024007089/ownership.xml","form_type":"4"}},{"id":1851400,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:30:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":105000,"derivative":{"exercise_price":0.495,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-037905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000120919123037905/doc4.xml","form_type":"4"}},{"id":1851490,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-16T16:06:36.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-23-005266","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023005266/primarydocument.xml","form_type":"4"}},{"id":1851489,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:06:36.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 10,000 RSUs from award granted on June 23, 2022; and (ii) 10,000 RSUs from award granted on June 15, 2023."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-23-005266","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023005266/primarydocument.xml","form_type":"4"}},{"id":2221817,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T16:51:28.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-22-005354","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022005354/primarydocument.xml","form_type":"4"}},{"id":2221816,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T16:51:28.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock"}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-22-005354","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022005354/primarydocument.xml","form_type":"4"}},{"id":2238696,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T20:10:14.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 7, 2023 or the date of the 2023 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":46000,"derivative":{"exercise_price":0.4747,"expiration_date":"2032-06-06","underlying":"Ordinary Shares","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001209191-22-035015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000120919122035015/doc4.xml","form_type":"4"}},{"id":2660154,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-06-21T16:45:03.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":52320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in thirty-six monthly installments at the end of each successive month following June 17, 2021, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":52320,"derivative":{"exercise_price":21.97,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":52320},"source":{"system":"sec-edgar","filing":"0001562180-21-004400","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218021004400/primarydocument.xml","form_type":"4"}},{"id":2662930,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:02:08.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 16, 2022 or the date of the 2022 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40000,"derivative":{"exercise_price":4.79,"expiration_date":"2031-06-15","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-041506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000120919121041506/doc4.xml","form_type":"4"}},{"id":2722847,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":22464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":22464},"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2722846,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":34416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":34416},"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2722845,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":3144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2722844,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":16548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.3342,"expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":16548},"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2722843,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":35340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":11.1742,"expiration_date":"2028-01-03","underlying":"Ordinary Shares","underlying_shares":35340},"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2722842,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":10584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018664/doc4.xml","form_type":"4"}},{"id":2819590,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-03-02T21:43:01.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-03-01","expiration_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-21-009227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009227/doc4.xml","form_type":"4"}},{"id":2819589,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:43:01.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":1260,"price":17.85,"value":22491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Mandatory withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":10584,"source":{"system":"sec-edgar","filing":"0000899243-21-009227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009227/doc4.xml","form_type":"4"}},{"id":2819588,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:43:01.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":3144,"price":0.0014,"value":4.4016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."}],"balance_after":11844,"source":{"system":"sec-edgar","filing":"0000899243-21-009227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009227/doc4.xml","form_type":"4"}},{"id":2832355,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-02-25T09:36:02.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":22464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan.  Inadvertently late filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":22464,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":22464},"source":{"system":"sec-edgar","filing":"0000899243-21-008161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008161/doc4.xml","form_type":"4"}},{"id":2915199,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2021-01-06T21:31:13.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.37 U.S. Dollars as of January 3, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":4,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-01-04","expiration_date":"2021-01-04","underlying":"Ordinary Shares","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0000899243-21-000785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000785/doc4.xml","form_type":"4"}},{"id":2915198,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:31:13.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":1440,"price":9.62,"value":13852.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Mandatory withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":8700,"source":{"system":"sec-edgar","filing":"0000899243-21-000785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000785/doc4.xml","form_type":"4"}},{"id":2915197,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:31:13.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":3576,"price":0.0014,"value":5.0064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.37 U.S. Dollars as of January 3, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excluding 9,868 ordinary shares underlying RSU-style share options previously reported in Column 5 of Table I, of which 3,580 ordinary shares vested on January 4, 2021 and 6,288 ordinary shares have not vested. Excluding 8 ordinary shares erroneously included in Column 5 of Table I of previous form 4s."}],"balance_after":10140,"source":{"system":"sec-edgar","filing":"0000899243-21-000785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321000785/doc4.xml","form_type":"4"}},{"id":3103911,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:21:49.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 17, 2021 or the date of the 2021 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":35000,"derivative":{"exercise_price":7.81,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-037926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584516/000120919120037926/doc4.xml","form_type":"4"}},{"id":3118517,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options","published_at":"2020-06-08T20:02:45.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":34416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These share options will vest in three equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":34416,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":34416},"source":{"system":"sec-edgar","filing":"0000899243-20-015692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015692/doc4.xml","form_type":"4"}},{"id":3227103,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-03-04T18:02:16.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":1296,"price":8.34,"value":10808.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale to cover vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":16440,"source":{"system":"sec-edgar","filing":"0000899243-20-006996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006996/doc4.xml","form_type":"4"}},{"id":3316329,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-07T17:01:05.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":1536,"price":8.53,"value":13102.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price per ordinary share ($102.35 per ADS). These share were sold in multiple transactions at prices ranging from $8.51 per ordinary share ($102.10 per ADS) to $8.53 per ordinary share ($102.36 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":17736,"source":{"system":"sec-edgar","filing":"0000899243-20-000727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320000727/doc4.xml","form_type":"4"}},{"id":3556518,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-04-12T17:30:56.000Z","date":"2019-03-13","kind":"sale","acquired":false,"shares":900,"price":14.2,"value":12780.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented by American Depositary Shares of the Issuer (\"ADSs\"). Each ADS represents twelve ordinary shares of the Issuer.  Inadvertently late filing."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":19272,"source":{"system":"sec-edgar","filing":"0000899243-19-010609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319010609/doc4.xml","form_type":"4"}},{"id":3592550,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-15T21:23:47.000Z","date":"2019-01-03","kind":"exercise","acquired":false,"shares":3580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of March 13, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.  Inadvertently late filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on March 15, 2022.  These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date. The correct vesting schedule of these restricted stock units is as follows: 3,580 ordinary shares vested on January 3, 2019; 3,580 ordinary shares will vest on January 3, 2020; and 3,580 ordinary shares will vest on January 3, 2021.  The remaining securities following the reported transaction are reported in Column 5 of Table I."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":3580},"source":{"system":"sec-edgar","filing":"0000899243-19-008036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319008036/doc4.xml","form_type":"4"}},{"id":3592549,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-03-15T21:23:47.000Z","date":"2019-01-03","kind":"exercise","acquired":true,"shares":3580,"price":0.0013,"value":4.654,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.  Inadvertently late filing."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of March 13, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,160 and 9,432 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively."}],"balance_after":20172,"source":{"system":"sec-edgar","filing":"0000899243-19-008036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319008036/doc4.xml","form_type":"4"}},{"id":3611734,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:10:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006342/doc4.xml","form_type":"4"}},{"id":3611733,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:10:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006342/doc4.xml","form_type":"4"}},{"id":3611732,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:10:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":3144,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0000899243-19-006342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006342/doc4.xml","form_type":"4"}},{"id":3611731,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-05T21:10:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":16548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The reported options are options to purchase American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price reported is price per ordinary share converted from price per ADS ($172.01)."}],"balance_after":16548,"derivative":{"exercise_price":14.33,"exercise_date":"2022-03-01","expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":16548},"source":{"system":"sec-edgar","filing":"0000899243-19-006342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006342/doc4.xml","form_type":"4"}},{"id":3843996,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Nonqualified Stock Option (right to buy)","published_at":"2018-08-15T16:18:17.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."}],"balance_after":0,"derivative":{"exercise_price":7.59,"expiration_date":"2023-07-20","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-046782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046782/doc4.xml","form_type":"4"}},{"id":3843995,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-15T16:18:17.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":127500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."}],"balance_after":0,"derivative":{"exercise_price":5.15,"expiration_date":"2024-03-03","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001209191-18-046782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046782/doc4.xml","form_type":"4"}},{"id":3843994,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-15T16:18:17.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":110000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."}],"balance_after":0,"derivative":{"exercise_price":7.9,"expiration_date":"2025-02-09","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-18-046782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046782/doc4.xml","form_type":"4"}},{"id":3843993,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-15T16:18:17.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":103855,"price":11.5,"value":1194332.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") among Catalent Pharma Solutions, Inc., Catalent Boston, Inc. and Juniper Pharmaceuticals Inc. (the \"Issuer\") dated as of July 2, 2018.  At the effective time of the merger (the \"Effective Time\") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock (other than appraisal shares and certain other shares), and each outstanding and unexercised Issuer stock option (whether vested or unvested) and each outstanding unvested restricted stock unit, immediately prior to the Effective Time were cancelled in exchange for $11.50 per share, net in cash, without interest, less any applicable taxes and applicable exercise price for the stock option (the \"Offer Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 87,650 restricted stock units that did not vest prior to the Effective Time of the merger.  Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unvested 87,650 restricted stock units was cancelled in exchange for the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-046782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046782/doc4.xml","form_type":"4"}},{"id":4012691,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-06T16:58:43.000Z","date":"2018-03-03","kind":"tax_withholding","acquired":false,"shares":1870,"price":8.8,"value":16456.0,"ownership":{"direct":true},"balance_after":86355,"source":{"system":"sec-edgar","filing":"0001209191-18-017344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118017344/doc4.xml","form_type":"4"}},{"id":4064330,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-13T16:12:24.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant."}],"balance_after":110000,"derivative":{"exercise_price":7.9,"expiration_date":"2028-02-09","underlying":"Common stock, $0.01 par value per share","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-18-009523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009523/doc4.xml","form_type":"4"}},{"id":4064329,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-13T16:12:24.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years."}],"balance_after":88225,"source":{"system":"sec-edgar","filing":"0001209191-18-009523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009523/doc4.xml","form_type":"4"}},{"id":4069379,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-09T19:46:12.000Z","date":"2018-02-07","kind":"tax_withholding","acquired":false,"shares":3475,"price":8.4,"value":29190.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The total number of shares acquired is net of the number of shares withheld for the payment of taxes."}],"balance_after":37725,"source":{"system":"sec-edgar","filing":"0001209191-18-009019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009019/doc4.xml","form_type":"4"}},{"id":4069378,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-09T19:46:12.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of JNP common stock issued upon partial vesting of a restricted stock unit award that vests upon the compensation committee's certification of the achievement of certain performance/milestone goals."}],"balance_after":41200,"source":{"system":"sec-edgar","filing":"0001209191-18-009019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009019/doc4.xml","form_type":"4"}},{"id":4398955,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-07T16:47:06.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant."}],"balance_after":127500,"derivative":{"exercise_price":5.15,"expiration_date":"2024-03-03","underlying":"Common Stock, $0.01 par value per share","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001209191-17-018771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117018771/doc4.xml","form_type":"4"}},{"id":4398954,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":36783,"kind":"person","name":"Secor Alicia","position":1,"cik":"0001584516","reported_name":"Secor Alicia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-07T16:47:06.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":26200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years."}],"balance_after":31200,"source":{"system":"sec-edgar","filing":"0001209191-17-018771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117018771/doc4.xml","form_type":"4"}}]}